Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07405099

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

Sponsor: National Taiwan University Hospital

View on ClinicalTrials.gov

Summary

End-stage renal disease (ESRD) patients often present risk factors for many surgical complications. The severity of renal failure and whether the patient is receiving renal replacement therapy are also related to the difficulty of pancreatic and other major surgeries, causing many ESRD patients to hesitate when choosing surgery. Therefore, this project aims to retrospectively collect basic data, preoperative and postoperative blood tests (blood cell counts, biochemistry, tumor markers, glucose-related, lipid-related), and preoperative and postoperative imaging examinations (CT, MRI, Ultrasound, PET scan, Endoscopy, etc.) of ESRD patients who underwent pancreatic surgery at our hospital.the investigators aim to compare whether surgical methods, severity of renal failure, use of renal replacement therapy, and lesion margin clearance rates affect the occurrence of surgical complications, length of hospital stay, length of ICU stay, re-operation rates or severe complications, medical costs, and related quality of life. This analysis is intended to understand and analyze the surgical prognosis, care priorities, common complications, and the management and outcomes of our team for ESRD patients undergoing pancreatic surgery, with the expectation of providing more diverse and specific treatment recommendations for these patients in the future.

Official title: The Analysis of End-stage Renal Disease for Outcomes in Pancreatic Surgery

Key Details

Gender

All

Age Range

20 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2016-01-01

Completion Date

2034-12-31

Last Updated

2026-02-27

Healthy Volunteers

No

Interventions

PROCEDURE

pancreatectomy

Any operation demanding pancreatic parenchyma transaction